Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Universe Pharmaceuticals (UPC)
NASDAQ:UPC
RESEARCH TOOLSreports
Holding UPC?
Track your performance easily
UPC Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.28 - $4.32
Previous Close$0.29
Volume3.04M
Average Volume (3M)2.18M
Market Cap
$6.95M
Enterprise Value-$6.07M
Total Cash (Recent Filing)$18.50M
Total Debt (Recent Filing)$5.48M
Price to Earnings (P/E)―
Beta-0.45
Next Earnings
Feb 04, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.70
Shares Outstanding23,650,000
10 Day Avg. Volume7,852,053
30 Day Avg. Volume2,182,663
Standard Deviation0.35
R-Squared0.06
Alpha-0.02
Financial Highlights & Ratios
Price to Book (P/B)0.18
Price to Sales (P/S)0.22
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit-0.59
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Universe Pharmaceuticals News
PremiumCompany Announcements
Universe Pharmaceuticals Announces Share Consolidation Plan
PremiumCompany Announcements
Universe Pharmaceuticals Faces Nasdaq Compliance Challenge
PremiumCompany Announcements
Universe Pharmaceuticals Confirms Financial Filing Accuracy
PremiumCompany Announcements
Universe Pharmaceuticals Secures Strong Shareholder Backing
PremiumCompany Announcements
Universe Pharmaceuticals Reports Financial DownturnOwnership Overview
0.00%
Insiders
<0.01% Mutual Funds
0.00% Other Institutional Investors
99.99% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
UPC FAQ
What was Universe Pharmaceuticals’s price range in the past 12 months?
Universe Pharmaceuticals lowest stock price was $0.28 and its highest was $4.32 in the past 12 months.
What is Universe Pharmaceuticals’s market cap?
Currently, no data Available
When is Universe Pharmaceuticals’s upcoming earnings report date?
Universe Pharmaceuticals’s upcoming earnings report date is Feb 04, 2025 which is in 75 days.
How were Universe Pharmaceuticals’s earnings last quarter?
Currently, no data Available
Is Universe Pharmaceuticals overvalued?
According to Wall Street analysts Universe Pharmaceuticals’s price is currently Overvalued.
Does Universe Pharmaceuticals pay dividends?
Universe Pharmaceuticals does not currently pay dividends.
What is Universe Pharmaceuticals’s EPS estimate?
Universe Pharmaceuticals’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Universe Pharmaceuticals have?
Universe Pharmaceuticals has 23,645,973 shares outstanding.
What happened to Universe Pharmaceuticals’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Universe Pharmaceuticals?
Currently, no hedge funds are holding shares in UPC
---
Universe Pharmaceuticals Stock Smart Score
Company Description
Universe Pharmaceuticals
Universe Pharmaceuticals Inc is a pharmaceutical company specializing in the manufacturing, marketing, sales and distribution of traditional Chinese medicine derivatives products targeting the elderly with the goal of addressing their physical conditions in the aging process and to promote their general well-being. The company also sells biomedical drugs medical instruments, Traditional Chinese Medicine Pieces, and dietary supplements manufactured by third-party pharmaceutical companies. Its products are under two categories namely treatment and relief for common chronic health conditions in the elderly designed to achieve physical wellness and longevity (Chronic Condition Treatments), and cold and flu medications.
---
Technical Analysis
SELLAS Life Sciences Group
―
Can-Fite BioPharma
―
CASI Pharmaceuticals
―
TRACON Pharmaceuticals
―
---